Evidence mapPaperPMID 41483032Full record

ArticlePflugers Archiv : European journal of physiology2026

Activation of the alternative complement pathway and its relevance for sodium retention in experimental nephrotic syndrome.

Daniel Essigke, M Zaher Kalo, Lingsi Kong, Matthias Wörn, Mohammad-Khaled Saad, Kingsley Omage, Bernhard N Bohnert, Andreas L Birkenfeld, John P Atkinson, Xiaobo Wu and 1 more

Abstract read
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Daniel EssigkeDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.ORCID 0000-0002-1473-377X
M Zaher KaloDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.
Lingsi KongDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.
Matthias WörnDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.
Mohammad-Khaled SaadDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.
Kingsley OmageDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.ORCID 0000-0001-7450-6731
Bernhard N BohnertDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.ORCID 0000-0003-0169-3948
Andreas L BirkenfeldDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany.ORCID 0000-0003-1407-9023
John P AtkinsonDepartment of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-2514-3441
Xiaobo WuDepartment of Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-6703-2272
Ferruh ArtuncDepartment of Internal Medicine, Division of Diabetology, Endocrinology and Nephrology, University Hospital Tübingen, Otfried-Mueller-Str.10, Tübingen, 72076, Germany. ferruh.artunc@med.uni-tuebingen.de.ORCID 0000-0002-3777-9316

Funding

NIH HHS NIH R35-GM136352
6 · The paper itself

Abstract

The complement component C3, factor B (FB) and factor D (FD) belong to the alternative complement pathway and have been identified in urine samples from nephrotic mice. However, it is not yet known whether these factors are involved in mediating sodium retention in nephrotic syndrome (NS). Here we used a genetic mouse model of NS based on an inducible podocin deletion (Nphs2

Indexed as

Complement Pathway, AlternativeNephrotic SyndromeSodiumAnimalsComplement C3Complement Factor BDisease Models, AnimalEpithelial Sodium ChannelsIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutComplement C3Complement Factor BEpithelial Sodium ChannelsIntracellular Signaling Peptides and ProteinsMembrane ProteinsNPHS2 proteinSodiumAlternative complement pathwayEdemaEpithelial sodium channelNephrotic syndromeSodium retention

Identifiers

PMID41483032
PMCPMC12764515

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.